Investment
Features
FeesSafety
Academy
More
Pluang+

Alector prices $75M stock offering to fund neurodegenerative disease therapies.

Company Fundamentals
16 Oct 2026
GlobeNewsWire
View Source
Neutral
Alector prices $75M stock offering to fund neurodegenerative disease therapies.

Alector, a biotech company focused on neurodegenerative diseases, announced an underwritten offering of 36.6 million common shares priced at $2.05 each, raising approximately $75 million before expenses. The offering includes participation from new and existing investors and is expected to close around October 19, 2026. Proceeds will support general corporate purposes such as research, development, manufacturing, and potential acquisitions. This financing aims to advance Alector's pipeline targeting diseases like Alzheimer's and Parkinson's using innovative therapies and delivery platforms.

Alector's recent underwritten offering is noted here for reader context. For those tracking health-sector stocks, 95 of 150 US stocks rose and 42 fell on Pluang today. Notable movers include HRTX at USD 0.39 (+3.05%, 60% Sell / 40% Buy, 36 days typical hold), WGS at USD 72.33 (+3.00%, 4% Sell / 96% Buy, 19 days typical hold), and MRVI at USD 6.91 (-2.26%, 1 day typical hold) as of Oct 16, 2026 18:11 WIB.

More News

Nasdaq resumes trading in CN Healthy Food Tech Group Corp. after year-long halt

Nasdaq resumes trading in CN Healthy Food Tech Group Corp. after year-long halt

Nasdaq announced that trading in CN Healthy Food Tech Group Corp.'s common stock and warrants will resume on October 19, 2026, after being halted since October 1, 2025. The resumption marks the end of a year-long trading suspension, allowing investor...

Market News
Neutral
30 minutes ago
Goldman Sachs CEO David Solomon named new chair of The Business Council, succeeding Brian Cornell.

Goldman Sachs CEO David Solomon named new chair of The Business Council, succeeding Brian Cornell.

David Solomon, CEO of Goldman Sachs, has been appointed as the new chair of The Business Council, taking over from Brian Cornell, Executive Chair of Target Corporation. This leadership change comes at a critical time as the Council addresses challeng...

Market News
Bullish
30 minutes ago
SEDA Experts appoints Noor Ul Islam as Managing Director to boost risk and securities expertise.

SEDA Experts appoints Noor Ul Islam as Managing Director to boost risk and securities expertise.

SEDA Experts LLC has appointed Noor Ul Islam as Managing Director, enhancing its capabilities in risk management and securities practices. With nearly 30 years of experience at major financial institutions like Citibank and Barclays, Islam brings dee...

Others
Neutral
30 minutes ago
Global pharmaceutical market to reach $3.22T by 2035, driven by biologics, AI drug discovery, and India’s 17.1% growth in 2026

Global pharmaceutical market to reach $3.22T by 2035, driven by biologics, AI drug discovery, and India’s 17.1% growth in 2026

The global pharmaceutical market is projected to grow from USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, expanding at a CAGR of 6.15%. Growth is fueled by advances in biologics, AI-driven drug discovery, specialty drugs, and manufacturing i...

Market News
Bullish
30 minutes ago
OAAA announces winners of the 84th OBIE Awards, honoring top creative work in out of home advertising.

OAAA announces winners of the 84th OBIE Awards, honoring top creative work in out of home advertising.

The Out of Home Advertising Association of America (OAAA) held the 84th Annual OBIE Awards in New York City, celebrating the best creative campaigns in out of home (OOH) advertising. Paramount was inducted into the OBIE Hall of Fame for its longstand...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App